Peptides for weight loss: what works and what is legal
Two drugs have FDA approval and large trials behind them for weight loss: semaglutide and tirzepatide. Everything else sold for fat loss is experimental, approved only abroad, or backed by animal data.
The short version
- Approved and proven: semaglutide (average 14.9% of body weight lost over 68 weeks in its main trial) and tirzepatide (20.9% over 72 weeks at the top dose).
- In trials, not legally for sale: retatrutide, cagrilintide and survodutide.
- Tested and failed: AOD-9604 showed no significant weight loss against placebo in its 536-person trial.
- If you start a GLP-1: part of the weight lost is muscle. See protein and muscle on GLP-1 medications.
Ready to start? HealthRX prescribes compounded semaglutide and tirzepatide online, with provider review in about 24 hours.
See today's prices at HealthRX →Affiliate link. Compounded medications are not FDA-approved. More below.
Better studied
Grades describe the evidence for a compound's best-studied use, which is not always the use on this page. The summary under each name says what was actually tested. How the grades work.
Semaglutide
Grade A FDA-approved
The most studied weight-loss drug available. Sold as Wegovy and Ozempic, as a weekly injection or a daily pill. Large trials behind it and a known side-effect profile.
Tirzepatide
Grade A FDA-approved
Acts on two hormone receptors instead of one. Sold as Zepbound and Mounjaro. Produced some of the largest weight reductions seen in obesity trials.
Tesamorelin
Grade A FDA-approved
The only growth-hormone-type drug with a current FDA approval. Narrowly approved to reduce excess abdominal fat in people with HIV and lipodystrophy; the fat returns if you stop.
Retatrutide
Grade B Investigational
Eli Lilly's experimental triple-hormone injection, with strong Phase 3 results and a planned FDA filing. Available only through clinical trials right now.
Mazdutide
Grade B Not in the US
A weekly weight-loss injection approved in China in 2025. Real approval, real trials, but no route to it in the United States.
Cagrilintide (and CagriSema)
Grade B Investigational
An amylin drug that, paired with semaglutide as CagriSema, produced about 20% weight loss in a large trial. Under FDA review; the FDA says it cannot be compounded.
Survodutide
Grade B Investigational
A weekly GLP-1 and glucagon injection with about 13% average weight loss in a 76-week Phase 3 trial. Not approved; stomach side effects were common.
AOD-9604
Grade B No legal route
Tested properly and failed. Its 536-person trial found no significant weight loss against placebo. Safety record was clean; the drug simply did not work.
L-carnitine (injectable)
Grade B Mixed
Approved for carnitine deficiency and sold as weight-loss shots. Dozens of trials, mostly oral, show about 1 kg of extra weight loss; the shots themselves are untested.
Little or no human evidence
5-amino-1MQ
Grade D No legal route
Not a peptide. Blocks an enzyme involved in NAD+ metabolism. Striking results in obese mice, zero published human trials, and a 40-fold spread in the doses people inject.
SLU-PP-332
Grade D No legal route
The "exercise pill." Mice ran 70% longer and obese mice lost weight. No human has been given it in a registered trial.
Adipotide
Grade D No legal route
Destroys the blood vessels feeding fat tissue. Produced about 11% weight loss in monkeys and damaged the kidneys of every treated animal at the same doses.
MOTS-c
Grade D 2026 policy
Encoded in mitochondrial DNA and marketed for metabolism and energy. Newly compoundable, with the human evidence still to come.
What you can legally get
- FDA-approved, by prescription: Semaglutide, Tirzepatide, Tesamorelin
- Compoundable on prescription under the October 2026 policy: MOTS-c
- Depends on the form (see the page): L-carnitine (injectable)
- In clinical trials only: Retatrutide, Cagrilintide (and CagriSema), Survodutide
- Approved abroad, not available in the US: Mazdutide
- No legal route in the US: AOD-9604, 5-amino-1MQ, SLU-PP-332, Adipotide
Products sold online as "research use only" are outside every one of these routes. See how to vet a provider.
Affiliate links
Start a GLP-1 online
HealthRX handles everything online. A licensed provider reviews your intake and, if you are approved, a US-licensed pharmacy ships the medication to your door.
- Provider review, usually within about 24 hours
- Free overnight shipping once you are approved
- Full refund if you are not approved
- LegitScript-certified, with no separate visit or membership fees
Prefer no needles? Strut Health offers compounded semaglutide as a weekly injection or a daily lozenge, with a free online doctor visit, free shipping and the option to cancel anytime.
See Strut Health's options →Affiliate links: Amino Desk earns a commission if you sign up, at no extra cost to you. Compounded medications are not FDA-approved, and a licensed provider decides whether one is right for you. How our partners score on our checks.
Keep reading
- Semaglutide vs tirzepatide
- What they cost
- Protein and muscle on GLP-1s
- What "GLP-3" and other seller code names mean
- Filter all 40 compounds by goal and legal status
This page summarizes our compound pages. The sources for every claim are listed on each of those pages.